Russian DefMin surprised by UNICEF inaction amid growing terrorist activity in SyriaRussian Politics & Diplomacy October 27, 23:14
Russian Defense Ministry: Video of airstrike on Syrian school doctored upRussian Politics & Diplomacy October 27, 21:22
Putin says its too early for him to retireSociety & Culture October 27, 21:10
Putin urges US not to provoke Russia to actively protect national interestsRussian Politics & Diplomacy October 27, 20:20
NATO’s actions create risks to European security — Russian NATO envoyRussian Politics & Diplomacy October 27, 19:52
Putin: Moscow ready to resume gas supplies to Ukraine on prepaid basisBusiness & Economy October 27, 19:47
Putin is sure Russia and Ukraine will find way to end crisisRussian Politics & Diplomacy October 27, 19:32
Refugee crisis demonstrates EU incapacities — Austria’s ex-presidentWorld October 27, 19:08
Putin urges new Marshall Plan for Middle East to see recovery and growthRussian Politics & Diplomacy October 27, 18:30
MOSCOW, June 19. /ITAR-TASS/. Russian pharmaceutical producer R-Pharm will invest €30 million in constructing a biotechnological plant in Turkey, CEO Vasily Ignatyev said late on Wednesday.
In 2013, R-Pharm established a joint venture with a Turkish partner aimed at selling R-Pharm’s medicines in Turkey, the Middle East and the northern Africa.
“We hope to get all necessary documents for clearance until the end of the year and to start the earthworks. We plan to finish the construction and to set up equipment until the end of 2016. The commercial launch will be made, as we expect, in late 2017,” Ignatyev said.
R-Pharm will invest €100 million in its Turkish business until 2018, he said.
Ignatyev separately said that the company will close the deal to purchase a plant from a large pharmaceutical company in Germany until the end of 2014.